4X52
Human PARP13 (ZC3HAV1), C-Terminal PARP Domain (H810N; N830Y variant)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | MAX II BEAMLINE I911-5 |
Synchrotron site | MAX II |
Beamline | I911-5 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2010-04-29 |
Detector | MAR CCD 165 mm |
Wavelength(s) | 0.90770 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 110.930, 50.000, 153.630 |
Unit cell angles | 90.00, 93.48, 90.00 |
Refinement procedure
Resolution | 29.700 - 2.080 |
R-factor | 0.2142 |
Rwork | 0.213 |
R-free | 0.23300 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | PDB 2x5y |
RMSD bond length | 0.012 |
RMSD bond angle | 1.070 |
Data reduction software | XDS |
Phasing software | MOLREP |
Refinement software | BUSTER (2.11.5) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.000 | 2.130 |
High resolution limit [Å] | 2.080 | 2.080 |
Rmerge | 0.084 | |
Number of reflections | 50705 | |
<I/σ(I)> | 14.5 | 1.5 |
Completeness [%] | 99.4 | 95.4 |
Redundancy | 4.3 | 4.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.4 | 277 | 25% PEG3350, 0.4M Ammonium sulfate, 0.1M Bis-Tris, 10mM 3-Aminobenzamide |